Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP
| Report ID | 136555 |
| Drug Identification Number | 02139499 |
| Brand name | MAGNESIUM SULFATE INJECTION |
| Common or Proper name | Magnesium Sulfate Injection 500 mg/mL SD Vial 10 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MAGNESIUM SULFATE |
| Strength(s) | 500MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-04-01 |
| Actual start date | 2021-04-01 |
| Estimated end date | 2022-04-30 |
| Actual end date | 2022-04-30 |
| Shortage status | Resolved |
| Updated date | 2022-05-01 |
| Company comments | On 100% Allocation effective October 13, 2021. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.